Singapore markets closed

Straits Times Index
3,394.21
+17.02(+0.50%)
Nikkei
27,382.56
+19.81(+0.07%)
Hang Seng
22,688.90
+122.12(+0.54%)
FTSE 100
7,765.15
+4.04(+0.05%)
BTC-USD
23,095.86
+278.98(+1.22%)
CMC Crypto 200
526.66
+9.65(+1.87%)

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

3.3400

+0.0600

(+1.83%)

At close: 04:00PM EST

3.4900

+0.15

(+4.49%)

After hours:

06:58PM EST

Loading interactive chart…

Zacks
Lyell Immunopharma (LYEL) Loses 21.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Lyell Immunopharma (LYEL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks
Lyell Immunopharma (LYEL) Reports Q3 Loss, Lags Revenue Estimates
Lyell Immunopharma (LYEL) delivered earnings and revenue surprises of 17.65% and 99.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Lyell Immunopharma (LYEL) Expected to Beat Earnings Estimates: Should You Buy?
Lyell Immunopharma (LYEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.